BTIG Research started coverage on shares of Apyx Medical (NASDAQ:APYX – Free Report) in a report released on Thursday morning, MarketBeat.com reports. The brokerage issued a neutral rating on the stock.
Separately, JMP Securities reissued a “market perform” rating on shares of Apyx Medical in a research report on Monday, September 16th.
Get Our Latest Analysis on APYX
Apyx Medical Stock Performance
Apyx Medical (NASDAQ:APYX – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.18) by ($0.01). Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. The firm had revenue of $12.15 million for the quarter, compared to the consensus estimate of $12.67 million. During the same quarter in the prior year, the firm earned ($0.11) EPS. On average, research analysts anticipate that Apyx Medical will post -0.7 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Apyx Medical
Several institutional investors have recently bought and sold shares of the stock. Kingsview Wealth Management LLC lifted its stake in Apyx Medical by 156.7% during the 1st quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock valued at $42,000 after acquiring an additional 18,943 shares in the last quarter. RPg Family Wealth Advisory LLC bought a new position in shares of Apyx Medical during the second quarter valued at about $101,000. Perkins Capital Management Inc. boosted its holdings in Apyx Medical by 7.0% during the first quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock worth $311,000 after purchasing an additional 15,000 shares during the last quarter. Rathbones Group PLC grew its position in Apyx Medical by 148.0% in the 2nd quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after purchasing an additional 150,000 shares in the last quarter. Finally, Commonwealth Equity Services LLC bought a new stake in Apyx Medical in the 1st quarter worth about $676,000. Institutional investors own 55.33% of the company’s stock.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
Read More
- Five stocks we like better than Apyx Medical
- What is the Euro STOXX 50 Index?
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is MarketRankā¢? How to Use it
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What is Put Option Volume?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.